Sign inJoin free

Watch / Three stocks for...

Marc's small cap value stocks

15 Oct 20256:10

Marc's small cap value stocks

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Key points:

- SkyCity Entertainment (ASX:SKC) seen trading below asset value with catalysts emerging

- Integral Diagnostics (ASX:IDX) described as undervalued, with scale benefits post-merger

- Amotiv (ASX:AOV) noted for steady growth, resilient aftermarket demand, and attractive yield

- Structural sector tailwinds, CEO changes, and new asset launches identified as important themes

Marc Whittaker from Investors Mutual shares focused views on value within the small caps universe, highlighting select opportunities in a challenging market for bargain-hunters. Whittaker singles out SkyCity Entertainment (ASX:SKC), noting its strong asset backing and current valuation at around half of net asset value. Despite regulatory headwinds in Adelaide and share price pressure, Whittaker sees potential for a turnaround. The Auckland casino remains a resilient asset, attracting increased visitor numbers even as per capita spend lags. An upcoming convention centre opening and signs of economic green shoots in New Zealand add to the positive outlook for SkyCity’s properties.

Integral Diagnostics (ASX:IDX) is also featured, with Whittaker pointing to its underappreciated status amid the market’s focus on resources and AI. With the group’s recent merger with Capital and deregulation in MRIs set to boost margins and volume, Whittaker believes scale and operational advantages are likely. He notes the sector benefits from structural tailwinds such as an ageing population and growing medical scan requirements. While a CEO transition presents some overhang, Whittaker remains confident in Integral Diagnostics’ prospects, citing its lower-than-private market valuation.

Moving to the auto space, Whittaker highlights Amotiv (ASX:AOV), praising its steady wear-and-tear business and resilient market demand. He sees consistent annual growth, a strong dividend yield, and potential for renewed interest as new vehicle sales lift.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy